| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 2e-06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |